Back to search

National and Kapodistrian University of Athens

Η συμβολή των ρυθμιστών του κυτταρικού κύκλου, της απόπτωσης και των διαβιβαστών μηνύματος στην εκτίμηση της έκβασης παιδιατρικών εμβρυονικών νεοπλασμάτων του κεντρικού νευρικού συστήματος

Abstract

dc:description

BackgroundMedulloblastomas (MBs), atypical teratoid/rhabdoid tumors (AT/RTs) and central nervous system primitive neuroectodermal tumors (PNETs) are aggressive embryonal brain neoplasms in children with overlapping histological features but with different pathogenetic pathways.Abnormalities of the cell cycle, apoptosis and signal transduction are molecular features of many brain tumors and are currently under evaluation for potential therapeutic intervention.Despite previous investigations, the role of p-53 tumor suppressor oncoprotein, cyclin Α, cyclin Β1, cyclin D3 and cyclin Ε, p27/kip-1 cyclin/CDK inhibitor, bcl-2 anti-apoptotic protein, epidermal growth factor receptor (EGFR), c-erbB2/HER-2 and c-kit in the pathogenesis of embryonal brain neoplasms has not been fully elucidated. The aim of this study was to investigate the expression of these regulators in pediatric embryonal brain tumors in correlation with histology, expression of the Ki-67/ MIB-1 proliferative index and prognosis.MethodWe evaluated 53 children with embryonic tumors that were diagnosed in the Hematology-Oncology Unit of Athens University, “Aghia Sofia” Children’s Hospital between January 1998 and January 2007, 30 males, 23 females, mean age 6,89 years, range 1 month to 15 years. Forty-two patients had a cerebellar MB. Histologically, 36 cases were classical undifferentiated MBs, 6 were desmoplastic MBs and 1 large cell/anaplastic MB. Nine patients had an AT/RT and 2 patients had a supratentorial PNET. The Bond Polymer Refine kit (Bond Vision Biosystems) on an automated staining system (Bond Max Vision Biosystems) was performed on paraffin sections for the detection of Ki-67/MIB-1, p53 (clone DO-7), cyclin A (clone 6E6), cyclin B1 (clone 7A9), cyclin D3 (clone DCS22), cyclin E (clone 13A), p27/kip-1 (clone B4), bcl-2 (clone 100D), EGFR (clone EGFR25), c-erbB2/HER-2 (clone CB11) and c-kit (clone T595). The appropriate negative and positive controls were used. Detection of Ki-67/MIB-1 and p-27/kip-1 in >50%, p53 protein, Cyclin B1, EGFR and c-kit in >15%, Cyclin A in >40%, Cyclin D3 in >10%, Cyclin E and bcl-2 in>30% and c-erb-B2 /HER2 in >20% of the Progression-free survival was defined as the time between initial surgery and demonstration of tumor progression on follow up imaging or death. Overall survival was defined as the time from surgery to death, or as the time to the last follow-up of the surviving patients. Survival curves were calculated and compared using the Kaplan-Meier method and the log-rank test. Multivariate analysis was performed using the forward stepwise Cox proportional hazard regression model. The following variables were entered: gender, age at diagnosis, histological subtype, and detection of Ki-67 >25%, p27/kip-1, p-53 and bcl-2 >10% of the neoplastic cells, membranous/nuclear detection of cyclin A and membranous/paranuclear of cyclin B1 >5% of the neoplastic cells, nuclear detection of cyclins D3 and E>5%, membranous/cytoplasmic detection of c-erbB2/HER-2 and c-kit in>10, cyclin Ε in >5%, and EGFR in >15%. A 2-sided p value <0.05 was considered statistically significant. We analyzed only the MBs because the number of AT/RTs and PNETs was limited.Three patients were lost to follow-up. After a mean follow up period of 4.4 years(range 6 months to 9.5 years) 30 patients were alive.ResultsHigh expression of Ki-67 (>25%) was observed in thirty-eight MBs being particularly increased (>50% of the nuclei) in 12 cases. All cases of AT/RTs expressed high Ki-67 (>25%), being particularly increased (>50%) in 4/9 cases. All PNETs showed increased Ki-67 (100%). All AT/RTs had increased p-53 (>15%). Two of them expressed p-53 above 50% of the nuclei. 1/2 PNETs expressed high p-53 (>50%).p53 protein was detected in 28/36 MBs showing a high expression (>15% of the nuclei) in 19 cases.Bcl-2 was observed in 11 MBs, in 7/9 cases of AT/RTs and in all PNETs. Cyclin Α was detected in 38 cases of MBs showing a high expression (>40%) in 11 cases. 6/9 AT/RTs expressed cyclin A showing a high expression in 2 cases. Cyclin A was detected in 1/2 PNETs. Cyclin Β1 was observed in 17/42 MBs showing a high expression (>15% of the nuclei) in 9 cases. It was expressed in 5/9 cases of AT/RTs. No expression of cyclin B was observed in any cases of PNETs. Cyclin D3 was releaved in 12/42 MBs showing a high expression (>10% of the nuclei) in 8 cases, while cyclin Ε was detected in 26/42 MBs showing a high expression (>30% of the nuclei) in 6 cases. Cyclin D3 was observed in 2/9 AT/RTs in hogh expression and in 1/2 cases of PNETs. Cyclin E was detected in all AT/RTs but not in any of the PNETs. p27/kip-1 was detected in all 42 MBs with a high expression (>50%) in 37 cases and in all cases of AT/RTs and PNETs. EGFR and c-kit were detected in 9 and 18MBs showing a high expression(>15%) in 8 and 15 cases respectively. EGFR was observed in 5/9 AT/RTs all in high exression while c-kit was expressed in 6/9 cases. EGFR was not expressed in any PNET while c-kit was expressed in 1/2. c-erbB2/HER-2 was observed in 32/42 MBs showing a high expression (>20%) in 23cases. cerbB2 was expressed in 8/9 AT/RTs and in 1/2 PNETs.ConclusionsOn the whole, from the present study the following conclusions are drawn:1) On multivariate analysis, only Ki-67 index was identified as a factor with independent prognostic power.2) In MB patients, Ki-67 index >50% was associated with worse survival.3) p27 was paradoxically expressed in the majority of our cases so it cannot be considered as a reliable index.4) High bcl-2 expression was associated with poorer prognosis.5) Low p53 expression was correlated with better prognosis.6) Cyclin D3 expression did not revealed any association with prognosis7) Cyclin A index >40% was associated with significantly poorer survival. To the best of our knowledge no other study has evaluated the role of cyclin A in patients with MB.8) Cyclin B1 expression was detected in a considerable number of cases, and there was a trend towards poorer survival for patients with cyclin B1 index more than 15%.10) EGFR, HER2 and c-kit expression is variable in pediatric brain tumors. Their expression in a considerable number of MBand ART suggests that it may be implicated in their pathogenesis representing a potential target for novel therapies.Study of the above indices at diagnosis could alter or intensify treatment methods, so as to improve disease outcome. There is obviously a need for future studies with larger number of patients to confirm our preliminary observations.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Patereli, Amalia
  • Πατερέλη, Αμαλία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/31677

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Patereli, Amalia; Πατερέλη, Αμαλία. Η συμβολή των ρυθμιστών του κυτταρικού κύκλου, της απόπτωσης και των διαβιβαστών μηνύματος στην εκτίμηση της έκβασης παιδιατρικών εμβρυονικών νεοπλασμάτων του κεντρικού νευρικού συστήματος. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/31677